Lipocine Inc.
LPCN· Nasdaq
Released Nov 7, 2024, before the open
10-Q filed Nov 7, 2024, 38 days after period end · 0001493152-24-043893
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | — | -$3.12M | — | $54.99K |
| Net Income | -$2.22M | -$6.65M | -$2.41M | -$3.08M |
| EPS Diluted | -$0.44 |
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR
| -$1.27 |
| -$0.52 |
| -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.